Read More

What’s Going On With EV-Maker Nikola’s Stock?

Last week, M&M Residual withdrew its nomination of five candidates for election to Nikola's board of directors and alleged "potentially fraudulent conduct of Nikola's management and certain directors." A previously filed SEC document dated April 10, included a note from Nikola's Chairman, Steven M. Shindler, highlighting the contentious battle for board seats to stockholders. "As you may have seen, M&M Residual, LLC, an entity controlled by criminally convicted former Executive Chairman Trevor Milton, has provided notice of its intent to nominate a slate of Directors," Shindler said.

NKLA

Read More

Why Edible Garden Stock Is Racing Higher

Edible Garden reported a preliminary first-quarter year-over-year increase in produce revenues of 40% and an increase in cut herb revenue of more than 200% compared to the same period last year. The company attributed the growth to its investments in equipment and infrastructure, as well as expanded retail distribution leading to a 12-fold increase in herb production.

EDBL

Read More

What’s Going On With CXAI Stock?

CXApp shares are trading higher Wednesday after the company announced record double digit Annual Recurring Revenue (ARR) growth in the fourth quarter of 2023 and 24% ARR growth for the full year 2023. CXAI attributed the ARR growth to two large Fortune 1000 logo contracts in the fourth quarter that are slated for deployment in the summer of 2024, leveraging the CXAI platform and in partnership with Google Cloud.

CXAI

Read More

What’s Going On With AMC Entertainment Stock?

AMC shares are rebounding on heavy trading volume Tuesday.  According to data from Benzinga Pro, more than 20 million shares have been traded in the session, compared to the stock's 100-day average of just over 14.5 million  shares. AMC's stock has grabbed the interest of short-sellers and retail investors alike. According to data from Benzinga Pro, 16.04% of available shares are being sold short which can contribute to large price moves when combined with heavy trading volume.

AMC

Read More

What’s Going On With Marijuana Grower Tilray’s Stock?

Cannabis companies' stocks have rallied recently on renewed optimism that the DEA may reschedule marijuana to a Schedule III substance. Last week, FDA Commissioner Robert Califf  told a House committee that there is  "no reason" for the DEA to delay the rescheduling of marijuana from Schedule 1 to Schedule 3 of the Controlled Substances Act. He also suggested medical and recreational marijuana could have separate regulations.

TLRY

Read More

Why Better Choice Stock Is Climbing Higher Today

Better Choice's board of directors has authorized a stock repurchase program under which the company can repurchase up to $5 million of the currently outstanding shares of its common stock, until Dec. 31, 2024. The company reported its fourth-quarter financial results Friday with losses of $6.51 per share and quarterly sales of $5.702 million.

BTTR

Read More

Why Jaguar Health Stock Is Up Today

Jaguar Health shares are trading higher Tuesday after the company announced it has signed an exclusive 5-year in-license agreement with Venture Life Group. The license agreement is for the U.S. market for Venture Life's FDA-approved prescription product, Gelclair. Gelclair is for the treatment of oral mucositis, also called "chemo mouth." "We are very happy to have executed the in-license agreement for Gelclair - and thus to have initiated Jaguar's commercial footprint in our core focus area of cancer supportive care," said Lisa Conte, Jaguar's president and CEO.

JAGX